August 28, 2025

9:00 am - 5:00 pm

Speakers & Panelists

Angie Santini, | Sr Scientist | 858 Therapeutics  |Talk: 858 Therapeutics Discovery and Characterization of the PARG Inhibitor ETX-19477

Duncan McColl | Dr of Engineering | Unnatural Products | Talk: CDD Vault Enhanced Engineering at Unnatural Products

A builder at heart, Duncan is driven by the challenge of shaping ideas into scalable systems that empower scientific discovery. As Director of Engineering at Unnatural Products, he leads engineering efforts and shape product direction to accelerate macrocycle drug discovery. Duncan began in cancer genomics at UCSC, applying ML to biological data, and found a passion for building clean, powerful tools that remove friction from scientific insight.

John Bucci |Research Informatics | Plexium | Talk: Building Seamless Data Pipelines for Efficient Drug Discovery and Collaboration

John Bucci is an informatician/data scientist with over 14 years of experience in biotech and drug discovery, specializing in developing automated data analysis pipelines, ML models and informatics solutions tailored for chemists and biologists. John is currently at Plexium in the Research Informatics group leveraging cheminformatics and data science techniques to support library chemistry and high throughput screening teams and accelerate drug discovery.

Dr. Mike Hanson | CEO | Atelier Therapeutics | Talk: Utilization and integration of CDD Vault in a startup biotech

Michael formed Atelier Therapeutics in 2024 to address a growing unmet need in chronic inflammation and neurodegenerative disorders. He has extensive experience in drug discovery, developing cutting edge technology, and entrepreneurship with previous roles as CSO of Abilita Bio, CTO & Founder of Structure Therapeutics, etc. Michael played a significant role in building and implementing a "toolbox" of techniques for protein chemistry and structural determination of integral membrane proteins such as GPCRs. He has led early-stage discovery and made inventive contributions to four clinical-stage programs, including Zeposia, an approved therapy for multiple sclerosis and ulcerative colitis.

Vladimir Makarov | AI Program Manager, Pistoia Alliance | Talk: Faster Drug Discovery through FAIR Standards

Vladimir Makarov is a highly creative and accomplished professional with deep expertise in bioinformatics, biotechnology, and AI. With a Ph.D. in Computational Biology from Baylor College of Medicine, he has built a dynamic career spanning scientific research, consulting, and strategic innovation. Currently consulting Pistoia Alliance as AI Program Manager, Vladimir is passionate about data quality and standardization. He also worked as a consultant for Pfizer and Amgen and as a Dr. of Bioinformatics at Exelixis and Monsanto.

Kellan Gregory is CDD’s Head of Products. He has a degree in Chemical Engineering with an emphasis in biotechnology from Tufts University. Kellan was co-author in an HIV study with Dr. Paul A. Volberding, and interned with BioRad and Libraria.

Janice Darlington | Customer Engagement Scientist | CDD | Talk: From Insight to Impact: Empowering Discovery Acceleration Through Integrated Technologies

Janice Darlington is a Customer Engagement Scientist at Collaborative Drug Discovery. She has supported CDD's scientific community in their research workflows since 2019. Her scientific background spans 27+ years in the San Diego drug discovery landscape.